CYP2D6 polymorphisms influence tamoxifen treatment outcomes in

Effects of CYP2D6 Genetic Polymorphism and Drug Interaction on the Metabolism of Dacomitinib

Influence of CYP2D6 Polymorphisms on Serum Levels of Tamoxifen Metabolites in Spanish Women with Breast Cancer

PDF] Does CYP2D6 Genotyping have a Role in Guiding Tamoxifen Therapy

CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects. - Abstract - Europe PMC

PDF) CYP2D6 polymorphisms influence tamoxifen treatment outcomes in breast cancer patients: A meta-analysis

Influence of CYP2D6, CYP2C19 and CYP3A5 polymorphisms on plasma levels of tamoxifen metabolites in Algerian women with ER+ breast cancer, Egyptian Journal of Medical Human Genetics

Pharmaceuticals, Free Full-Text

CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial - ScienceDirect

SciELO - Brasil - Impacts of Cytochrome P450 2D6 (CYP2D6) Genetic Polymorphism in Tamoxifen Therapy for Breast Cancer Impactos do polimorfismo genético do citocromo P450 2D6 (CYP2D6) na terapia com tamoxifeno para

CYP2D6 polymorphisms and tamoxifen adverse effects - Video Abstract ID 126557

Frontiers Clinical Trial: CYP2D6 Related Dose Escalation of Tamoxifen in Breast Cancer Patients With Iranian Ethnic Background Resulted in Increased Concentrations of Tamoxifen and Its Metabolites

Important and critical scientific aspects in pharmacogenomics analysis: lessons from controversial results of tamoxifen and CYP2D6 studies

Effect of CYP2C19 genotypes on tamoxifen metabolism and early-breast cancer relapse